Efficacy and Safety of Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study

被引:1
|
作者
Forester, Brent [1 ,2 ]
Sajatovic, Martha [3 ]
Tsai, Joyce [4 ,5 ]
Kroger, Hans [4 ,5 ]
Pikalov, Andrei [4 ,5 ]
Cucchiaro, Josephine [4 ,5 ]
Loebel, Antony [4 ,5 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] McLean Hosp, Belmont, MA 02178 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Sunov Pharmaceut Inc, Marlborough, MA USA
[5] Sunov Pharmaceut Inc, Ft Lee, NJ USA
来源
关键词
D O I
10.1016/j.jagp.2014.12.178
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
NR 25
引用
下载
收藏
页码:S170 / S171
页数:3
相关论文
共 50 条
  • [1] Efficacy and safety of long-term treatment with lurasidone in older adults with bipolar depression: results of a 6 month open-label study
    Forester, B.
    Sajatovic, M.
    Tsai, J.
    Kroger, H.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2015, 17 : 132 - 132
  • [2] Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study
    Forester, B.
    Sajatovic, M.
    Tsai, J.
    Kroger, H.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [3] Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study
    Forester, Brent P.
    Sajatovic, Martha
    Tsai, Joyce
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (02): : 150 - 159
  • [4] Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study
    Ketter, Terence A.
    Amchin, Jess
    Frye, Mark A.
    Gross, Nicholas
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 : 51 - 57
  • [5] LONG-TERM SAFETY AND TOLERABILITY OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A 6-MONTH, OPEN-LABEL STUDY
    Stahl, Steven M.
    Cucchiaro, Josephine
    Simonelli, D.
    Severs, J.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 322 - 322
  • [6] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [7] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [8] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Chang, K.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S81 - S82
  • [9] SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: WEEK 28 RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Chang, Kiki
    DelBello, Melissa P.
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei A.
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S163 - S163
  • [10] Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66